24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
CartiHeal
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:12
Inside Intel’s biggest-ever layoff: a blueprint for a wounded giant
08:47
“I forged the contract”: Promai CEO allegedly confesses in sting to faking Boeing deal with ChatGPT
07:40
Full list of Israeli high-tech layoffs in 2025
07:36
Intel to lay off more than 20,000 workers as new CEO begins overhaul
More stories
Buzz
Most popular
Daily
Weekly
1
“I don’t want to be the richest man in the cemetery” — Morris Kahn on giving it all away at 95
2
Ex-Unit 8200 commander’s startup raises $50 million to fight AI-driven data leaks
3
Romance, lies, and ChatGPT: The scandal shaking Tel Aviv’s startup scene
4
A $35 million VC fund was born at a Gaza war crossing
5
Hopper emerges from stealth with $7.6 million to rethink open-source security
More news
CartiHeal
3 stories about CartiHeal
Biomed company CartiHeal acquired by Smith & Nephew for up to $330 million
22.11.23
|
Meir Orbach
The Israeli firm, which develops a biocompatible, coral-based, off-the-shelf implant for damaged joints, will initially receive $180 million in cash and up to a further $150 million contingent on financial performance
Israeli medtech company CartiHeal to be acquired for $500 million by Bioventus
30.08.21
|
Golan Hazani
The American orthobiologics company announced that it has activated its option to purchase the Kfar Saba-based company by transferring an initial $50 million
Biomed Company CartiHeal Considers a Nasdaq IPO
26.02.20
|
Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter